The latest on . . .

EU ‘preparing to sue’ AstraZeneca over missing Covid doses

Ireland’s health minister confirms that Brussels is considering a possible lawsuit over delivery shortfall

The European Commission is looking at taking vaccine producer AstraZeneca to court for cutting Covid vaccine deliveries, Ireland’s health minister has confirmed.

The issue was raised during a meeting of EU ambassadors yesterday, “during which the majority of EU countries said they would support suing the company” after “it massively failed to deliver pledged doses to the bloc”, Politico reported last night. One diplomat said the ultimate aim was to ensure that the Cambridge-based company delivered the promised number of doses.

Stephen Donnelly told the Irish parliament today that the legal case had “been initiated” around AstraZeneca’s “complete failure to meet its delivery and contractual agreements for April, May and June”, Sky News reports. However, a European Commission spokesperson told the broadcaster: “The decision to take legal action has not been taken at this point in time.”

An EU official told Reuters: “It is about fulfilment of deliveries by the end of the second quarter.”

The bloc signed an agreement with AstraZeneca for the delivery of 300 million vaccines by the end of June, but the pharma giant announced last month that only 70 million would be handed over to the EU27 by that deadline.

The company has come under fire after cutting supplies several times to levels much lower than promised, with the European Commission blaming the “shortfalls in AstraZeneca deliveries for the slow pace of its vaccination rollout”, says The Telegraph.

The newspaper predicted that any legal action would probably come down to a dispute over “breach of contract”, with Brussels accusing AstraZeneca of reneging on its deal amid “suspicions that some EU stock may have gone to Britain or other countries”. AstraZeneca denies the allegations.

A senior EU source said yesterday that the bloc will also not use an option to secure a total 300 million extra doses of AstraZeneca and Johnson & Johnson vaccines that the bloc secured under existing contracts, reports Reuters’ EU correspondent Francesco Guarascio.

The decision is another clear “sign Brussels is looking to distance itself from AstraZeneca”, Guarascio adds, following a public rebuke of the EU from the pharmaceutical company’s CEO in January.

A string of EU countries have suspended the use of the Oxford-AstraZeneca vaccine among some or all age groups amid concerns about rare blood clots

However, the bloc is pushing to speed up its rollout, with latest Oxford University tracking showing that it has administered 117.8 million vaccines so far - which equates to just 26.49 per 100 people having received at least one dose. 

Recommended

Is Bosnia on the brink of another civil war?
Bosnian Serb leader Milorad Dodik
In Depth

Is Bosnia on the brink of another civil war?

Who will win the French election 2022?
French President Emmanuel Macron
In Focus

Who will win the French election 2022?

The ‘prime suspect’ in Anne Frank’s betrayal
Anne Frank
Between the lines

The ‘prime suspect’ in Anne Frank’s betrayal

‘PM calls in military’
Today's newspaper front pages
Today’s newspapers

‘PM calls in military’

Popular articles

Djokovic vs. Nadal vs. Federer: career records and grand slams
Novak Djokovic, Rafael Nadal and Roger Federer have all won 20 grand slam singles titles
Profile

Djokovic vs. Nadal vs. Federer: career records and grand slams

RSPCA reveals its funniest call-outs
RSPCA officers
Tall Tales

RSPCA reveals its funniest call-outs

Why is the UK in pole position to emerge from Covid-19 first?
A woman wearing a face mask waits for the tube in London
Today’s big question

Why is the UK in pole position to emerge from Covid-19 first?

The Week Footer Banner